Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126025561 | 12602556 | 1 | I | 20160721 | 20160728 | 20160728 | EXP | PHHY2016RS101253 | NOVARTIS | DOKIC M, UROSEVIC I, SAVIC I, SEKULIC B, SAVIC A, MILOSEVIC I ET AL.. A CASE OF CHRONIC LYMPHOCYTIC LEUKAEMIA OCCURRING DURING TREATMENT OF CHRONIC MYELOID LEUKAEMIA. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION. 2016;32 (SUPPL 1):S156-S158 | 64.00 | YR | F | Y | 0.00000 | 20160728 | OT | RS | RS |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126025561 | 12602556 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Unknown | 400 MG, QD | 21588 | 400 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126025561 | 12602556 | 1 | Chronic myeloid leukaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126025561 | 12602556 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126025561 | 12602556 | Chronic lymphocytic leukaemia | |
| 126025561 | 12602556 | Conjunctivitis | |
| 126025561 | 12602556 | Leukocytosis | |
| 126025561 | 12602556 | Lymphocytosis | |
| 126025561 | 12602556 | Muscle spasms | |
| 126025561 | 12602556 | Second primary malignancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |